Features | Princeton Public Health Review

Meningitis is an infection in the membrane layers surrounding the brain and the spinal cord called the meninges. It is airborne and is spread through close contact such as coughing or sneezing. The outbreak is related to type B (serogroup B) meningococcal bacteria which is the cause of the eight cases of meningitis at the University. The vaccine Bexsero has recently been developed and licensed in Europe and Australia to protect against type B (serogroup B) meningococcal disease. As has been announced by the Centers of Disease Control and Prevention (CDC) and Princeton University, the meningitis cases have been declared to be an outbreak. As a result, the CDC is importing Bexsero for use among students at Princeton University.

PPHR spoke with Dr. Thomas Clark, the head of CDC’s meningitis and vaccine preventable disease branch. Continue reading Q&A with Head of CDC’s Meningitis and Vaccine Preventable Disease Branch Dr. Thomas Clark →

Statistics illustrate the extent to which Alzheimer’s disease is prevalent in the United States. It is the sixth leading cause of death in the United States and nearly 5.2 million Americans of all ages have this disease in 2013. In fact, it is estimated that in 2013, Alzheimer’s will cost the nation nearly $203 billion and the cost is expected to rise to $1.2 trillion by the end of 2050.² These numbers all raise concerns as to what is essentially going on about Alzheimer’s research, diagnosis, treatments and prevention.

November is Alzheimer’s Awareness Month. The Princeton Public Health Review reached out to Dr. Neil Buckholtz, the Director of the Division of Neuroscience at the National Institute of Aging (NIA). Continue reading Alzheimer’s Research–The Road Ahead: A Q&A with the NIA Director of Neuroscience →

Princeton's premier global health journal